Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
| Actual shortage: | 241 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT LEVOFLOXACIN | 750MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110655 |
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2020-04-23 | 2020-08-27 | 113010 |
| ACT LEVOFLOXACIN | 750MG | TABLET | Resolved | 2020-08-06 | 2020-08-27 | 121855 |
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2020-09-17 | 2020-12-17 | 124468 |
| ACT LEVOFLOXACIN | 750MG | TABLET | Resolved | 2021-08-27 | 2023-06-09 | 144694 |
| ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2021-11-25 | 2022-02-05 | 149934 |
| ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2022-10-28 | 2023-06-09 | 173040 |
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-06-08 | 2023-10-04 | 194106 |
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-06-19 | 2023-10-04 | 195484 |
| ACT LEVOFLOXACIN | 750MG | TABLET | Actual shortage | 2024-03-07 | 2024-03-07 | 221531 |
| TEVA-FENTANYL | 75MCG | PATCH | Resolved | 2019-07-02 | 2019-08-06 | 88158 |
| TEVA-FENTANYL | 75MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173013 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Resolved | 2018-03-13 | 2018-05-11 | 42573 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Resolved | 2018-03-13 | 2018-05-30 | 42616 |
| TEVA-DICLOFENAC SR | 75MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2018-10-23 | 2020-02-13 | 65490 |
| TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2018-12-04 | 2019-06-03 | 68616 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2019-06-13 | 2019-07-15 | 86599 |
| TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2019-08-22 | 2021-05-06 | 92171 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-08-22 | 2020-02-08 | 92201 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-09-05 | 2020-02-08 | 93146 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| RATIO-METFORMIN | 850MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120012 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |